Shareholders who lost money in shares of The Chemours Company (NYSE: CC) should contact Wolf Haldenstein Immediately
Lead Plaintiff Deadline December 7, 2026 NEW YORK, Oct. 26, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a nationally recognized securities litigation law firm announces that a securities class action lawsuit has been filed in the United States...
Covered in this story
Analyst targets on Chemours
- RBC Capital Markets: $13.4 → $14 by Oct 2027 · Sector Perform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Chemours →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.